Skip to main content
Open Access Publications from the University of California

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma

  • Author(s): Daud, A
  • Kluger, HM
  • Kurzrock, R
  • Schimmoller, F
  • Weitzman, AL
  • Samuel, TA
  • Moussa, AH
  • Gordon, MS
  • Shapiro, GI
  • et al.

Published Web Location
No data is associated with this publication.
Item not freely available? Link broken?
Report a problem accessing this item